96 related articles for article (PubMed ID: 2851504)
21. The side-effects of cardiopulmonary bypass on the lungs: changes in bronchoalveolar lavage fluids.
Alat I; Yüksel M; Büket S; Nalbantgil S; Aşkar F; Bayindir U; Taşbakan S; Kokuludag A; Veral A
Perfusion; 2001 Mar; 16(2):121-8. PubMed ID: 11334195
[TBL] [Abstract][Full Text] [Related]
22. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects.
Keatings VM; Barnes PJ
Am J Respir Crit Care Med; 1997 Feb; 155(2):449-53. PubMed ID: 9032177
[TBL] [Abstract][Full Text] [Related]
23. IL-8 and the activation of eosinophils and neutrophils following nasal allergen challenge.
Jacobi HH; Poulsen LK; Reimert CM; Skov PS; Ulfgren AK; Jones I; Elfman LB; Malling HJ; Mygind N
Int Arch Allergy Immunol; 1998 May; 116(1):53-9. PubMed ID: 9623510
[TBL] [Abstract][Full Text] [Related]
24. [Diagnostic value of secretory products of eosinophils and neutrophils in bronchoalveolar lavage in patients with idiopathic lung fibrosis].
Pohl WR; Schenk E; Umek H; Micksche M; Kummer F; Köhn H
Wien Klin Wochenschr; 1993; 105(14):387-92. PubMed ID: 8396288
[TBL] [Abstract][Full Text] [Related]
25. The distribution of myeloperoxidase, eosinophil cationic protein, albumin and urea in sequential bronchoalveolar lavage.
Schmekel B; Venge P
Eur Respir J; 1991 May; 4(5):517-23. PubMed ID: 1657631
[TBL] [Abstract][Full Text] [Related]
26. Sequential studies on serum-levels of lysozyme, lactoferrin and eosinophil cationic protein in alcoholics after alcohol withdrawal.
Lundin L; Hällgren R; Venge P
Scand J Haematol; 1980 Nov; 25(5):431-8. PubMed ID: 7013020
[TBL] [Abstract][Full Text] [Related]
27. Elevated circulating levels of eosinophil cationic protein in uremia as signs of abnormal eosinophil homeostasis.
Hällgren R; Grefberg N; Venge P
Nephron; 1984; 36(1):10-4. PubMed ID: 6690999
[TBL] [Abstract][Full Text] [Related]
28. Eosinophil granule proteins activate human heart mast cells.
Patella V; de Crescenzo G; Marinò I; Genovese A; Adt M; Gleich GJ; Marone G
J Immunol; 1996 Aug; 157(3):1219-25. PubMed ID: 8757629
[TBL] [Abstract][Full Text] [Related]
29. Eosinophil soluble protein levels, eosinophil peroxidase and eosinophil cationic protein in asthmatic patients.
Parra A; Sanz ML; Vila L; Prieto I; Diéguez I; Oehling AK
J Investig Allergol Clin Immunol; 1999; 9(1):27-34. PubMed ID: 10212854
[TBL] [Abstract][Full Text] [Related]
30. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease.
Saitoh O; Kojima K; Sugi K; Matsuse R; Uchida K; Tabata K; Nakagawa K; Kayazawa M; Hirata I; Katsu K
Am J Gastroenterol; 1999 Dec; 94(12):3513-20. PubMed ID: 10606313
[TBL] [Abstract][Full Text] [Related]
31. Eosinophil involvement in rheumatoid arthritis as reflected by elevated serum levels of eosinophil cationic protein.
Hällgren R; Feltelius N; Svenson K; Venge P
Clin Exp Immunol; 1985 Mar; 59(3):539-46. PubMed ID: 3987090
[TBL] [Abstract][Full Text] [Related]
32. Neutrophil elastase and elastase-rich cystic fibrosis sputum degranulate human eosinophils in vitro.
Liu H; Lazarus SC; Caughey GH; Fahy JV
Am J Physiol; 1999 Jan; 276(1):L28-34. PubMed ID: 9887052
[TBL] [Abstract][Full Text] [Related]
33. Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome.
Kristjánsson G; Venge P; Wanders A; Lööf L; Hällgren R
Gut; 2004 Dec; 53(12):1806-12. PubMed ID: 15542519
[TBL] [Abstract][Full Text] [Related]
34. [Eosinophil cationic protein in patients with bronchial asthma].
Numao T; Fukuda T; Hirata A; Sagara H; Majima K; Nakajima H; Akutsu I; Ando N; Makino S
Arerugi; 1991 Feb; 40(2):93-9. PubMed ID: 1712583
[TBL] [Abstract][Full Text] [Related]
35. Activated eosinophils in adult coeliac disease: evidence for a local release of major basic protein.
Colombel JF; Torpier G; Janin A; Klein O; Cortot A; Capron M
Gut; 1992 Sep; 33(9):1190-4. PubMed ID: 1427370
[TBL] [Abstract][Full Text] [Related]
36. Serum eosinophil cationic protein and bronchial hyperresponsiveness to hypoosmolar challenge in naive atopic asthmatics.
Dal Negro R; Tognella S; Micheletto C; Pomari C; Burti E; Mauroner L; Turco P
J Investig Allergol Clin Immunol; 1998; 8(5):294-9. PubMed ID: 9827426
[TBL] [Abstract][Full Text] [Related]
37. Serum ECP and MPO are increased during exacerbations of chronic bronchitis with airway obstruction.
Fiorini G; Crespi S; Rinaldi M; Oberti E; Vigorelli R; Palmieri G
Biomed Pharmacother; 2000 Jun; 54(5):274-8. PubMed ID: 10917466
[TBL] [Abstract][Full Text] [Related]
38. Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease.
Bischoff SC; Mayer J; Nguyen QT; Stolte M; Manns MP
Am J Gastroenterol; 1999 Dec; 94(12):3521-9. PubMed ID: 10606314
[TBL] [Abstract][Full Text] [Related]
39. [Cell activation markers in rhinitis and rhinosinusitis. 1: Eosinophilic cationic protein (ECP)].
Klimek L; Rasp G
Laryngorhinootologie; 1996 Nov; 75(11):665-70. PubMed ID: 9063834
[TBL] [Abstract][Full Text] [Related]
40. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction.
Ohnishi T; Kita H; Weiler D; Sur S; Sedgwick JB; Calhoun WJ; Busse WW; Abrams JS; Gleich GJ
Am Rev Respir Dis; 1993 Apr; 147(4):901-7. PubMed ID: 8466126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
